Photodynamic therapy in the management of bladder cancer

Journal of Clinical Laser Medicine and Surgery

Volumn 14, Issue 5, 1996, Pages 271-280

  Nseyo, Unyime O ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; DRUG THERAPY; LASER APPLICATIONS; LASER TISSUE INTERACTION; ONCOLOGY; PHOTOCHEMICAL REACTIONS; PHOTOSENSITIVITY;

LOCAL MORBIDITY; SUPERFICIAL BLADDER CANCER; TRANSITIONAL CELL CARCINOMA;

PHOTODYNAMIC THERAPY;

BCG VACCINE; DOXORUBICIN; HEMATOPORPHYRIN DERIVATIVE; MITOMYCIN C; PHOTOFRIN; PHOTOFRIN II; THIOTEPA;

ADULT; AGED; ARGON LASER; ARTICLE; BLADDER CANCER; CARCINOMA IN SITU; CLINICAL FEATURE; CLINICAL PROTOCOL; DOSE RESPONSE; DYE LASER; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; INTRAVESICAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PAPILLARY CARCINOMA; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PROPHYLAXIS; SUPERFICIAL CANCER; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME;

EID: 0030273145     PISSN: 10445471     EISSN: None     Source Type: Journal    
DOI: 10.1089/clm.1996.14.271     Document Type: Article

References (23)

1. Parker, S.L., Tong, T., Bolden, S., and Wingo, P.A. (1996). Cancer Statistics, 1996. CA Cancer J. Clin. 46, 5-27.
2. Cohen, S.M., and Lohansson, S.L. (1992). Epidemiology and etiology of bladder cancer. Urol. Clin. N. Am. 19(3), 421.
3. Lamm, D.L. (1992). Carcinoma in situ. Urol. Clin. N. Am. 19(3), 499.
4. Utz, D.C., Hanash, K.A., and Farrow, G.M. (1970). The plight of the patient with carcinoma in situ of the bladder. J. Urol. 103, 160.
5. Abel, P.D. (1993). Follow-up of patients with "superficial" transitional cell carcinoma of the bladder: The case for a change in policy. Br. J. Urol. 72, 135.
6. Traynelis, C.L., and Lamm, D.L. (1994). Current status of intravesical therapy for bladder cancer, in: Urology Annual, Vol. 8. S.N. Rous (ed.). New York: W.W. Norton, pp. 113.
7. Lamm, D.L. (1995). BCG in prospective advances in the treatment of superficial bladder cancer. Eur. Urol. (Suppl. 1), 2.
8. Coplen, D.E., Marcus, M.D., Myers, J.A., Ratliff, T.L., and Catalona, W.J. (1990). Long-term follow-up of patients treated with 1 or 2,6 week courses of intravesical bacillus calmette-guerin analysis of possible predictors of response free of tumor. J. Urol. 144, 652.
9. Bretton, P.R., Herr, H.W., Kimmel, M., Whitmore, W.F., Jr., Laudone, V., Oettgen, H.F., and Fair, W.R. (1990). The response of patients with superficial bladder cancer to a second course of intravesical bacillus calmette-guerin. J. Urol. 143, 710.
10. Nseyo, U.O. (1992). Photodynamic therapy. Urol. Clin. N. Am. 19, 591.
11. Hisazumi, H., Misaki, T., Miyoshi, N., et al. (1983). Photoradiation therapy of bladder tumors. J. Urol. 130, 685.
12. Ohi, T., and Tsuchiya, A. (1983). Superficial bladder tumors, in: Lasers and Hematoporphyrin in Cancer. Y. Hayata and T.J. Dougherty (eds.). Tokyo: Igaku-shoin, pp. 79-84.
13. Prout, G.R., Lin, C.W., Benson, R., et al. (1987). Photodynamic therapy with Hpd in the treatment of superficial transitional cell carcinoma of the bladder. N. Engl. J. Med. 317, 1251.
14. Benson, R.C., Jr. (1988). Treatment of bladder cancer with hematoporphyrin derivatives and laser light. Urology 23(Suppl.), 13.
15. Shumaker, B.P., and Hetzel, RW. (1987). Clinical laser photodynamic therapy in the treatment of bladder carcinoma. Photochem. Photobiol. 46(5), 899.
16. Jocham, D., Beer, M., Baumgartner, R., Staehler, G., and Unsold, E. (1989). Long-term experience with integral photodynamic therapy of TIS bladder carcinoma. Ciba Found. Symp. 146, 198.
17. D'Hallewin, M.A., and Baert, L. (1995). Long-term results of whole bladder wall photodynamic therapy for carcinoma-in-situ of the bladder. Urology 45, 763.
18. Manyak, M.J., Cole, J.W,. McNellis, K.J., and Smith, P.D. (1992). Downstaging of BCG-resistant carcinoma-in-situ of the bladder by photodynamic therapy with intravesical diffusion medium. J. Urol. Part 2, 147, 374A, Abstract 6488.
19. Kreigmair, M., Wiadelich, R., Lumper, W., Ehsan, A., Baumgartner, R., and Hostetter, A. (1995). Integral photodynamic therapy treatment of refractory superficial bladder cancer. J. Urol. 154, 1339.
20. Nseyo, U.O., Crawford, E.D., Shumaker, B., et al. (1995). Photodynamic Therapy as an Alternative to Cystectomy in Refractory CIS, American Association of Cancer Research Annual Meeting, April 17-21, 1995, Toronto, Canada.
21. Dugan, M., Crawford, E.D., Nseyo, U.O., et al. (1991). Photodynamic therapy (PDT) after transurethral resection (TUR) for superficial papillary bladder cancer (SBC): A randomized trial [abstract]. Proc. Am. Soc. Clin. Oncol. 10, 554.
22. Dougherty, T.J. (1989). Photodynamic therapy: Status and potential. Oncology 3, 67.
23. Harty, J.I., Amin, M., Weiman, T.J., et al. (1989). Complications of whole bladder dihematoporphyrin ether photodynamic therapy. J. Urol. 141, 1341.